Patnaik Santosh Kumar, Potvin Barry, Carlsson Susanne, Sturm David, Leffler Hakon, Stanley Pamela
Department of Cell Biology, Albert Einstein Collegeof Medicine, New York, NY 10461 USA.
Glycobiology. 2006 Apr;16(4):305-17. doi: 10.1093/glycob/cwj063. Epub 2005 Nov 29.
Galectins are implicated in a large variety of biological functions, many of which depend on their carbohydrate-binding ability. Fifteen members of the family have been identified in vertebrates based on binding to galactose (Gal) that is mediated by one or two, evolutionarily conserved, carbohydrate-recognition domains (CRDs). Variations in glycan structures expressed on glycoconjugates at the cell surface may, therefore, affect galectin binding and functions. To identify roles for different glycans in the binding of the three types of mammalian galectins to cells, we performed fluorescence cytometry at 4 degrees C with recombinant rat galectin-1, human galectin-3, and three forms of human galectin-8, to Chinese hamster ovary (CHO) cells and 12 different CHO glycosylation mutants. All galectin species bound to parent CHO cells and binding was inhibited >90% by 0.2 M lactose. Galectin-8 isoforms with either a long or a short inter-CRD linker bound similarly to CHO cells. However, a truncated form of galectin-8 containing only the N-terminal CRD bound only weakly to CHO cells and the C-terminal galectin-8 CRD exhibited extremely low binding. Binding of the galectins to the different CHO glycosylation mutants revealed that complex N-glycans are the major ligands for each galectin except the N-terminal CRD of galectins-8, and also identified some fine differences in glycan recognition. Interestingly, increased binding of galectin-1 at 4 degrees C correlated with increased propidium iodide (PI) uptake, whereas galectin-3 or -8 binding did not induce permeability to PI. The CHO glycosylation mutants with various repertoires of cell surface glycans are a useful tool for investigating galectin-cell interactions as they present complex and simple glycans in a natural mixture of multivalent protein and lipid glycoconjugates anchored in a cell membrane.
半乳糖凝集素与多种生物学功能有关,其中许多功能取决于它们的碳水化合物结合能力。基于与半乳糖(Gal)的结合,该家族在脊椎动物中已鉴定出15个成员,这种结合由一个或两个进化上保守的碳水化合物识别结构域(CRD)介导。因此,细胞表面糖缀合物上表达的聚糖结构变化可能会影响半乳糖凝集素的结合和功能。为了确定不同聚糖在三种类型的哺乳动物半乳糖凝集素与细胞结合中的作用,我们在4℃下用重组大鼠半乳糖凝集素-1、人半乳糖凝集素-3和三种形式的人半乳糖凝集素-8对中国仓鼠卵巢(CHO)细胞和12种不同的CHO糖基化突变体进行了荧光细胞术分析。所有半乳糖凝集素都与亲本CHO细胞结合,并且0.2 M乳糖可抑制>90%的结合。具有长或短CRD间连接子的半乳糖凝集素-8同工型与CHO细胞的结合相似。然而,仅包含N端CRD的截短形式的半乳糖凝集素-8与CHO细胞的结合较弱,而C端半乳糖凝集素-8 CRD的结合极低。半乳糖凝集素与不同的CHO糖基化突变体的结合表明,复杂N-聚糖是除半乳糖凝集素-8的N端CRD外每种半乳糖凝集素的主要配体,并且还确定了聚糖识别方面的一些细微差异。有趣的是,4℃下半乳糖凝集素-1结合的增加与碘化丙啶(PI)摄取的增加相关,而半乳糖凝集素-3或-8的结合不会诱导对PI的通透性。具有各种细胞表面聚糖组成的CHO糖基化突变体是研究半乳糖凝集素-细胞相互作用的有用工具,因为它们在锚定在细胞膜中的多价蛋白质和脂质糖缀合物的天然混合物中呈现复杂和简单的聚糖。